A comprehensive view of Merck KGaA. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
Recent Articles
sample of recent headlines, press releases and get more..
Merck KGaA doubles US viral gene therapy capacity with new €100M, 140,000 square-foot facility in Carlsbad, California; Merck Life Sciences awarded €121M contract from US Dept. of Defense to build lateral flow membrane facility in Sheboygan, Wisconsin
Published:
July 01, 2022
by CE NAFTA 2.0 Newswire
|
Merck investing €290M to expand membrane immersion casting manufacturing capacity at Carrigtwohill, Ireland, plant, and €150M to build new filtration manufacturing plant in Cork, Ireland; investments will create more than 370 jobs
Published:
May 26, 2022
by ENP Newswire
|
Merck KGaA's Q1 net profit up 18.2% from a year ago to €884.0M, with revenue up 12.2% year-over-year €5.2B; growth driven by new health care products, process solutions, semiconductor solutions, with CEO saying firm not reliant on COVID-19 for growth
Published:
May 16, 2022
by SeeNews Pharmaceuticals (
|
Merck KGaA's MilliporeSigma acquires Lonza’s MAST platform, an automated aseptic bioreactor sampling system to advance bioprocessing; platform offers real-time data to cut process development time by half, lower biopharmaceutical manufacturing costs
Published:
April 13, 2022
by PR Newswire
|
Merck KGaA’s Iriotec 8000 series pigments, granules create permanent identification marks on plastic using lasers to aid in reuse, recycling of plastics; unlike inkjet marking or stick-on labels, laser marking requires no solvent-based inks or adhesives
Published:
April 08, 2022
by Merck KGaA
|
Ask us about our Health Care Sector market view
Trending Chart
Interactive chart with headline count